Protein kinases and phosphatases as therapeutic targets in cancer.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Juan-José Ventura, Angel R Nebreda

Abstract

Protein phosphorylation plays key roles in many physiological processes and is often deregulated in pathological conditions. Our current understanding of how protein kinases and phosphatases orchestrate the phosphorylation changes that control cellular functions has made these enzymes potential drug targets for the treatment of many diseases. The success of the tyrosine kinase inhibitor Gleevec in the treatment of some cancers has further invigorated the development of kinase inhibitors as anti-cancer drugs. A large number of these compounds are currently undergoing clinical trials and there is much expectation on the therapeutic potential of these molecules, as more specific and less toxic drugs than currently used generic chemotherapeutic agents. In this manuscript, we review the current status of more than 30 protein kinase inhibitors with proven or potential therapeutic value for cancer treatment. These include inhibitors of receptor and cytosolic tyrosine kinases as well as compounds that target different families of serine/threonine kinases involved in signalling and cell cycle regulation. We also briefly touch on the prospects of phosphatase inhibitors. The combination of kinase inhibitors to target different components ...Continue Reading

References

Nov 1, 2000·Cell·J Schlessinger
Jul 18, 2002·Nature Reviews. Drug Discovery·Philip Cohen
Jul 18, 2002·Nature Reviews. Drug Discovery·Margaret A Somerville
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Dec 10, 2002·Science·G ManningS Sudarsanam
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jan 2, 2003·Nature Reviews. Cancer·Julian Downward
Feb 26, 2003·The Biochemical Journal·Ricardo M Biondi, Angel R Nebreda
Mar 18, 2003·Cellular Signalling·Huira ChongKun-Liang Guan
Apr 2, 2003·Nature Reviews. Drug Discovery·Janet Dancey, Edward A Sausville
Jun 5, 2003·Cancer Cell·Jiri Bartek, Jiri Lukas
Jun 20, 2003·Nature Reviews. Drug Discovery·Anthony M Manning, Roger J Davis
Aug 28, 2003·Current Opinion in Chemical Biology·Oliver M FischerAxel Ullrich
Jan 7, 2004·Nature Reviews. Molecular Cell Biology·Oliver Hantschel, Giulio Superti-Furga
Mar 20, 2004·Science·Martin E M NobleLouise N Johnson
Apr 23, 2004·Trends in Molecular Medicine·James M Olson, Andrew R Hallahan
Jun 10, 2004·Cell·Andres AlonsoTomas Mustelin
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isabelle Sansal, William R Sellers
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Aug 25, 2004·Chemistry & Biology·K Kristjánsdóttir, J Rudolph
Aug 26, 2004·British Journal of Haematology·Dai WatanabeTadamitsu Kishimoto
Nov 9, 2004·Advances in Cancer Research·Dmitry V Bulavin, Albert J Fornace
Dec 2, 2004·Nature Reviews. Cancer·Nicholas Keen, Stephen Taylor
Dec 2, 2004·Nature Reviews. Cancer·Judith S Sebolt-Leopold, Roman Herrera
Jan 11, 2005·Oncogene·Frank EckerdtKlaus Strebhardt
Mar 16, 2005·Cancer Cell·Kiranmai GumireddyE Premkumar Reddy
Mar 23, 2005·Current Opinion in Cell Biology·Monica Gallego, David M Virshup
Apr 1, 2005·Seminars in Oncology·Funda Meric-Bernstam, Gordon B Mills
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Alexander P DucruetJohn S Lazo
May 4, 2005·Trends in Cell Biology·Régis GietClaude Prigent
Jun 21, 2005·Current Opinion in Pharmacology·Ian Collins, Michelle D Garrett
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Muralidhar BeeramEric K Rowinsky
Sep 24, 2005·Leukemia·G MartinelliM Baccarani
Oct 6, 2005·Cell Cycle·Christian RécherBernard Payrastre
Oct 21, 2005·Trends in Biochemical Sciences·Marcos Malumbres, Mariano Barbacid
Nov 8, 2005·Nature·David B SolitNeal Rosen
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Nov 17, 2005·Oncogene·Jin Q ChengSanto V Nicosia
Nov 17, 2005·Oncogene·Chandra C Kumar, Vincent Madison
Jan 18, 2006·Cancer Cell·Marcos Malumbres, Mariano Barbacid

❮ Previous
Next ❯

Citations

Feb 9, 2008·Cancer Metastasis Reviews·Zhong-Xing Jiang, Zhong-Yin Zhang
Jun 23, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Marcos Malumbres
Sep 19, 2009·Monash Bioethics Review·George F Tomossy
Apr 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Irina AlhoConstança Coelho
May 29, 2009·The Journal of Biological Chemistry·Ole VielemeyerFranck Perez
Sep 17, 2008·BMC Genomics·Jonathan M Wilkes, Christian Doerig
Jan 4, 2007·Proteome Science·Anouk EmadaliEric Chevet
Jul 30, 2011·Future Microbiology·Kellie Burnside, Lakshmi Rajagopal
Aug 25, 2007·Pharmacogenomics·Georgios GiamasUwe Knippschild
Feb 16, 2012·Expert Opinion on Therapeutic Patents·Masilamani Elizabeth SobhiaThongtinlal Haokip
Jun 15, 2010·Biotechnology Advances·Jeong-Hun KangYoshiki Katayama
Dec 1, 2007·Analytical Biochemistry·Ganesh H IyerS Pazhanisamy
Jul 24, 2012·The FEBS Journal·Rongjun HeZhong-Yin Zhang
Jun 12, 2008·Redox Report : Communications in Free Radical Research·Alexandra NowakRüdiger Hardeland
Jan 30, 2015·British Journal of Pharmacology·Doriano FabbroHenrik Moebitz
Jun 23, 2009·Leukemia Research·Mirna Mourtada-Maarabouni, Gwyn T Williams
May 1, 2007·Drug Discovery Today·Sheng Zhang, Zhong-Yin Zhang
Feb 10, 2007·Expert Review of Proteomics·Shi-Jian DingRichard D Smith
Jul 20, 2007·Genes, Chromosomes & Cancer·Mohammad H RazviWael El-Rifai
May 20, 2008·Nature Chemical Biology·Christian D Doerig
Jul 2, 2010·Biopolymers·Ding WuStephen J Kron
Apr 16, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Inés G MuñozGuillermo Montoya
Jan 26, 2007·Journal of Medicinal Chemistry·Irene G BoutselisRichard F Borch
Jun 18, 2014·Biochemistry·Zhi-Hong YuZhong-Yin Zhang
May 29, 2020·Journal of Medicinal Chemistry·Xinrui YuanHuibin Zhang
Jan 28, 2014·Journal of Chemical Information and Modeling·Yongmei PanStephen H Bryant
Apr 22, 2018·Journal of Proteome Research·Brittany N PeaseDebopam Chakrabarti
Jul 9, 2014·Journal of Medicinal Chemistry·Li-Fan ZengZhong-Yin Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.